Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 335

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 218

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 325

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 395

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 276

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 221

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 206

Aceruloplasminemia Presenting with Cognitive Impairment

Yıldız Arslan, Ufuk Şener, Alp Sarıteke, Yaşar Zorlu

DOI: 10.4274/tnd.37640

Issue: 2017, Volume 23 - Issue 3
0 260

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 236

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 200

Neuropsychiatric Symptoms due to Artemisia Absinthium Poisoning

Yavuz Altunkaynak, Nurhak Demir, Devrimsel Harika Ertem, Ayten Ceyhan Dirican, Ayhan Köksal

DOI: 10.4274/tnd.47108

Issue: 2017, Volume 23 - Issue 2
0 239

Major Vascular Neurocognitive Disorder: A Reappraisal to Vascular Dementia

Emre Kumral, Ozan Özgören

DOI: 10.4274/tnd.98250

Issue: 2017, Volume 23 - Issue 1
0 331

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 231

Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Tuncay Gündüz

DOI: 10.4274/tnd.28566

Issue: 2016, Volume 22 - Issue 4
0 242

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Serhan Sevim

DOI: 10.4274/tnd.75318

Issue: 2016, Volume 22 - Issue 3
0 347

Evaluation of Thalamus Area In Essential Tremor Patients With Proton Magnetik Resonance Spectroscopy

Adile Ozkan, Fatma Candan, Nihal Işık, İlknur Aydın Cantürk, Semra Arı, Özgür Öztop Çakmak, Tunahan Ayaz

DOI: 10.4274/tnd.67044

Issue: 2015, Volume 21 - Issue 4
0 266

Isolated Complete Horizontal Gaze Palsy and Multiple Sclerosis

Hakan Tekeli, Mustafa Tansel Kendirli, Mehmet Güney Şenol, Rıfat Erdem Toğrol, Mehmet Fatih Özdağ, Serkan Demir

DOI: 10.4274/tnd.93899

Issue: 2015, Volume 21 - Issue 4
0 249

A Case Followed as Having Multiple Sclerosis but Diagnosed with Secondary Brain Lymphoma

Serkan Demir, Rıfat Erdem Toğrol, Ali&775; Rıza Sonkaya, Tolga Tuncel

DOI: 10.4274/tnd.70845

Issue: 2015, Volume 21 - Issue 3
0 317

Do steroids trigger mania in multiple sclerosis? Not always!

Serhan Sevim, Serhan Karakılıç, Ayşe Devrim Başterzi, Mefkure Eraksoy

DOI: 10.4274/tnd.91328

Issue: 2015, Volume 21 - Issue 2
0 383

Multiple Sclerosis and Dentistry: A Contemporary Evaluation

Hasan Hatipoğlu, Sibel Canbaz Kabay, Müjgan Güngör Hatipoğlu

DOI: 10.4274/tnd.29974

Issue: 2015, Volume 21 - Issue 1
0 387